Check-CapSTU:7CC +15.51%32 Market Cap is €8.49 Mil as of Jun. 30, 2026. GuruFocus rates STU:7CC with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 218 Medical Diagnostics & Research companies, Check-Cap ranks worse than 83.94% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Check-Cap's share price for the quarter that ended in Dec. 2025 was €1.41. Check-Cap's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 7.02 Mil. Therefore, Check-Cap's market cap for the quarter that ended in Dec. 2025 was €9.90 Mil.
Check-Cap's quarterly market cap
declined
from Dec. 2024 (€6.09 Mil) to Jun. 2025 (€3.80 Mil) but then
increased
from Jun. 2025 (€3.80 Mil) to Dec. 2025 (€9.90 Mil).
Check-Cap's annual market cap
declined
from Dec. 2023 (€11.41 Mil) to Dec. 2024 (€6.09 Mil) but then
increased
from Dec. 2024 (€6.09 Mil) to Dec. 2025 (€9.90 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Check-Cap's Enterprise Value for Today is €8.31 Mil.
Check-Cap (STU:7CC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Check-Cap Market Cap Related Terms
Check-Cap Market Cap Historical Data
* Premium members only.
The historical data trend for Check-Cap's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:7CC vs ADVB, XWEL, NDRA: Market Cap Comparison
For the Diagnostics & Research subindustry, Check-Cap's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Check-Cap Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Check-Cap's Market Cap distribution charts can be found below:
* The bar in red indicates where Check-Cap's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Check-Cap's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Check-Cap (STU:7CC) has a Market Cap of €8.49 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Check-Cap and its competitors. According to the industry distribution chart, Check-Cap ranks #183 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 83.9%.
Is Check-Cap's Market Cap too high?
Check-Cap's current Market Cap is €8.49 Mil. Based on the distribution chart, Check-Cap ranks #183 out of 218 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Check-Cap has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Check-Cap's Market Cap compare to ADVB and XWEL?
According to the Medical Diagnostics & Research industry distribution chart, Check-Cap ranks #183 out of 218 companies for Market Cap. This places Check-Cap in the lower half of its industry. The industry median Market Cap is 54.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 54.77, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Check-Cap and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 54.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Check-Cap's current Market Cap is €8.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Check-Cap stock overvalued right now?
Check-Cap (STU:7CC) has a current Market Cap of €8.49 Mil. The current Market Cap is €8.49 Mil. Check-Cap's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Check-Cap (STU:7CC), the current Market Cap is €8.49 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.
32GF Score
Get the complete analysis for STU:7CC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:7CC has been successfully added to your 
